Free Stock Analysis Report: Buy Sell Hold Predictions on Any Stock
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Analyze Any Stock Free

CERE Insider Trading

Insider Ownership Percentage: 5.10%
Insider Buying (Last 12 Months): $2,510,922.12
Insider Selling (Last 12 Months): $19,428,510.25

Cerevel Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Cerevel Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cerevel Therapeutics Share Price & Price History

Current Price: $20.10
Price Change: Price Decrease of -0.53 (-2.57%)
As of 09/22/2023 12:21 PM ET

This chart shows the closing price history over time for CERE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cerevel Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/7/2023N Anthony ColesDirectorSell50,000$24.07$1,203,500.002,704View SEC Filing Icon  
8/4/2023Paul D BurgessInsiderBuy21,880$22.93$501,708.4021,880View SEC Filing Icon  
8/3/2023Ronald C Renaud JrCEOBuy83,857$23.96$2,009,213.7283,857View SEC Filing Icon  
7/11/2023N Anthony ColesDirectorSell50,000$30.03$1,501,500.002,704View SEC Filing Icon  
6/15/2023Marijn E DekkersDirectorSell200,000$34.43$6,886,000.00402,326View SEC Filing Icon  
6/2/2023Mark BodenraderInsiderSell1,895$32.95$62,440.255,522View SEC Filing Icon  
6/1/2023N Anthony ColesCEOSell50,000$32.60$1,630,000.002,704View SEC Filing Icon  
5/4/2023N Anthony ColesCEOSell50,000$31.47$1,573,500.002,704View SEC Filing Icon  
4/11/2023N Anthony ColesCEOSell50,000$25.06$1,253,000.002,704View SEC Filing Icon  
3/3/2023N Anthony ColesCEOSell3,000$27.19$81,570.002,704View SEC Filing Icon  
2/7/2023N Anthony ColesCEOSell50,000$33.13$1,656,500.002,704View SEC Filing Icon  
1/5/2023N Anthony ColesCEOSell50,000$29.94$1,497,000.002,704View SEC Filing Icon  
12/9/2022N Anthony ColesCEOSell50,000$26.67$1,333,500.002,704View SEC Filing Icon  
10/4/2022John RengerInsiderSell25,000$30.00$750,000.002,704View SEC Filing Icon  
9/12/2022Deval L. PatrickDirectorSell47,705$30.78$1,468,359.90View SEC Filing Icon  
9/8/2022Abraham CeesayPresidentSell19,210$32.50$624,325.00View SEC Filing Icon  
8/22/2022Abraham CeesayPresidentSell9,605$32.50$312,162.50View SEC Filing Icon  
8/16/2022Perceptive Advisors LlcDirectorBuy1,425,000$35.00$49,875,000.006,511,727View SEC Filing Icon  
8/10/2022John RengerInsiderSell55,000$40.50$2,227,500.002,704View SEC Filing Icon  
7/20/2022John RengerInsiderSell25,000$30.00$750,000.002,704View SEC Filing Icon  
7/5/2022John RengerInsiderSell25,000$30.00$750,000.002,704View SEC Filing Icon  
4/13/2022John RengerInsiderSell45,000$34.65$1,559,250.001,980View SEC Filing Icon  
3/29/2022John RengerInsiderSell10,000$35.00$350,000.00View SEC Filing Icon  
3/18/2022John RengerInsiderSell20,000$32.50$650,000.00View SEC Filing Icon  
3/16/2022John RengerInsiderSell25,000$30.00$750,000.00View SEC Filing Icon  
2/9/2022John RengerInsiderSell25,000$30.00$750,000.00View SEC Filing Icon  
12/27/2021John RengerInsiderSell4,127$35.00$144,445.00View SEC Filing Icon  
12/23/2021John RengerInsiderSell5,873$35.00$205,555.00View SEC Filing Icon  
12/21/2021John RengerInsiderSell7,300$32.50$237,250.00View SEC Filing Icon  
12/17/2021John RengerInsiderSell7,122$32.50$231,465.00View SEC Filing Icon  
12/15/2021John RengerInsiderSell25,000$30.02$750,500.00View SEC Filing Icon  
11/10/2021John RengerInsiderSell55,000$39.86$2,192,300.00View SEC Filing Icon  
8/25/2021Perceptive Advisors LlcDirectorBuy61,387$28.57$1,753,826.59View SEC Filing Icon  
8/23/2021Perceptive Advisors LlcDirectorBuy44,437$25.78$1,145,585.86View SEC Filing Icon  
7/7/2021Perceptive Advisors LlcDirectorBuy200,000$25.00$5,000,000.00View SEC Filing Icon  
6/17/2021Gabrielle SulzbergerDirectorBuy21,084$13.06$275,357.0435,354View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Cerevel Therapeutics (NASDAQ:CERE)

87.73% of Cerevel Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CERE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cerevel Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/21/2023Barclays PLC131,342$4.18M0.0%-78.1%0.083%Search for SEC Filing on Google Icon
8/24/2023Perceptive Advisors LLC10,088,385$320.71M9.3%+54.9%6.406%Search for SEC Filing on Google Icon
8/21/2023Affinity Asset Advisors LLC550,000$17.48M6.0%+44.7%0.349%Search for SEC Filing on Google Icon
8/21/2023California State Teachers Retirement System75,724$2.41M0.0%-0.7%0.048%Search for SEC Filing on Google Icon
8/15/2023Alliancebernstein L.P.90,540$2.88M0.0%+34.7%0.057%Search for SEC Filing on Google Icon
8/15/2023Wells Fargo & Company MN63,629$2.02M0.0%+4.5%0.040%Search for SEC Filing on Google Icon
8/15/2023Eventide Asset Management LLC490,000$15.58M0.3%+57.1%0.311%Search for SEC Filing on Google Icon
8/15/2023Woodline Partners LP794,919$25.27M0.3%+30.0%0.505%Search for SEC Filing on Google Icon
8/15/2023Goldman Sachs Group Inc.363,704$11.56M0.0%-3.5%0.231%Search for SEC Filing on Google Icon
8/15/2023Lazard Asset Management LLC7,336$0.23M0.0%-9.2%0.005%Search for SEC Filing on Google Icon
8/15/2023Royal Bank of Canada4,050$0.13M0.0%+18.6%0.003%Search for SEC Filing on Google Icon
8/14/2023NinePointTwo Capital LLC8,151$0.26M0.1%N/A0.005%Search for SEC Filing on Google Icon
8/14/2023Tower Research Capital LLC TRC 4,262$0.14M0.0%+59.4%0.003%Search for SEC Filing on Google Icon
8/14/2023Schonfeld Strategic Advisors LLC66,390$2.11M0.0%N/A0.042%Search for SEC Filing on Google Icon
8/14/2023State of Wisconsin Investment Board54,747$1.74M0.0%-5.1%0.035%Search for SEC Filing on Google Icon
8/14/2023State Street Corp2,768,277$88M0.0%-11.8%1.758%Search for SEC Filing on Google Icon
8/14/2023Jefferies Financial Group Inc.25,000$0.80M0.0%-50.0%0.016%Search for SEC Filing on Google Icon
8/14/2023UniSuper Management Pty Ltd97,429$3.10M0.0%N/A0.062%Search for SEC Filing on Google Icon
8/14/2023Nuveen Asset Management LLC149,716$4.76M0.0%+4.8%0.095%Search for SEC Filing on Google Icon
8/14/2023Polar Capital Holdings Plc910,762$28.95M0.2%+18.5%0.578%Search for SEC Filing on Google Icon
8/14/2023Graham Capital Management L.P.10,344$0.33M0.0%N/A0.007%Search for SEC Filing on Google Icon
8/11/2023Credit Suisse AG72,773$2.31M0.0%+31.2%0.046%Search for SEC Filing on Google Icon
8/11/2023BlackRock Inc.4,832,707$153.63M0.0%+7.8%3.081%Search for SEC Filing on Google Icon
8/11/2023Ameritas Investment Partners Inc.5,110$0.16M0.0%+11.5%0.003%Search for SEC Filing on Google Icon
8/11/2023State Board of Administration of Florida Retirement System17,570$0.56M0.0%+24.9%0.011%Search for SEC Filing on Google Icon
8/11/2023The Manufacturers Life Insurance Company 146,096$4.64M0.0%+14.7%0.093%Search for SEC Filing on Google Icon
8/11/2023Guggenheim Capital LLC13,367$0.43M0.0%+12.1%0.009%Search for SEC Filing on Google Icon
8/11/2023Geode Capital Management LLC1,346,029$42.79M0.0%+7.0%0.858%Search for SEC Filing on Google Icon
8/11/2023Artal Group S.A.1,638,858$52.10M1.6%-14.4%1.045%Search for SEC Filing on Google Icon
8/11/2023Sei Investments Co.14,960$0.48M0.0%+17.8%0.010%Search for SEC Filing on Google Icon
8/11/2023E Fund Management Co. Ltd.9,501$0.30M0.0%-20.4%0.006%Search for SEC Filing on Google Icon
8/11/2023PNC Financial Services Group Inc.5,640$0.18M0.0%N/A0.004%Search for SEC Filing on Google Icon
8/11/2023Northern Trust Corp583,278$18.54M0.0%+5.4%0.372%Search for SEC Filing on Google Icon
8/11/2023ExodusPoint Capital Management LP15,245$0.49M0.0%N/A0.010%Search for SEC Filing on Google Icon
8/10/2023MetLife Investment Management LLC32,786$1.04M0.0%+7.8%0.021%Search for SEC Filing on Google Icon
8/10/2023ProShare Advisors LLC8,048$0.26M0.0%N/A0.005%Search for SEC Filing on Google Icon
8/10/2023Profund Advisors LLC32,605$1.04M0.1%-17.1%0.021%Search for SEC Filing on Google Icon
8/10/2023Mirae Asset Global Investments Co. Ltd.33,888$1.08M0.0%+3.4%0.022%Search for SEC Filing on Google Icon
8/10/2023Charles Schwab Investment Management Inc.501,983$15.96M0.0%+3.1%0.320%Search for SEC Filing on Google Icon
8/10/2023Citigroup Inc.68,279$2.17M0.0%-59.5%0.044%Search for SEC Filing on Google Icon
8/9/2023TD Asset Management Inc203,449$6.47M0.0%+12.3%0.130%Search for SEC Filing on Google Icon
8/9/2023Swiss National Bank136,400$4.34M0.0%+1.0%0.087%Search for SEC Filing on Google Icon
8/8/2023Rhumbline Advisers88,268$2.81M0.0%+5.4%0.056%Search for SEC Filing on Google Icon
8/7/2023Principal Financial Group Inc.26,572$0.85M0.0%-5.7%0.017%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.29,785$0.95M0.0%+7.7%0.019%Search for SEC Filing on Google Icon
8/3/2023Barclays PLC131,342$4.18M0.0%-78.1%0.084%Search for SEC Filing on Google Icon
8/3/2023Bank of New York Mellon Corp260,100$8.27M0.0%+10.4%0.166%Search for SEC Filing on Google Icon
8/2/2023State of New Jersey Common Pension Fund D73,492$2.34M0.0%N/A0.047%Search for SEC Filing on Google Icon
8/2/2023Handelsbanken Fonder AB11,600$0.37M0.0%+28.9%0.007%Search for SEC Filing on Google Icon
8/1/2023Arizona State Retirement System17,601$0.56M0.0%-2.9%0.011%Search for SEC Filing on Google Icon
7/31/2023Duality Advisers LP16,094$0.51M0.1%N/A0.010%Search for SEC Filing on Google Icon
7/31/2023Strs Ohio10,200$0.32M0.0%+161.5%0.007%Search for SEC Filing on Google Icon
7/27/2023Victory Capital Management Inc.7,377$0.24M0.0%N/A0.005%Search for SEC Filing on Google Icon
7/27/2023Virtu Financial LLC14,053$0.45M0.0%N/A0.009%Search for SEC Filing on Google Icon
7/19/2023Teacher Retirement System of Texas17,000$0.54M0.0%-11.7%0.011%Search for SEC Filing on Google Icon
7/10/2023SG Americas Securities LLC4,556$0.15M0.0%-84.5%0.003%Search for SEC Filing on Google Icon
5/18/2023New York State Common Retirement Fund30,487$0.74M0.0%-26.0%0.019%Search for SEC Filing on Google Icon
5/16/2023Hudson Bay Capital Management LP40,000$0.98M0.0%-20.0%0.026%Search for SEC Filing on Google Icon
5/16/2023State Street Corp3,137,586$76.53M0.0%-8.4%2.001%Search for SEC Filing on Google Icon
5/16/2023Squarepoint Ops LLC32,300$0.79M0.0%-40.0%0.021%Search for SEC Filing on Google Icon
5/16/2023Geode Capital Management LLC1,257,920$30.68M0.0%+4.5%0.802%Search for SEC Filing on Google Icon
5/16/2023AQR Capital Management LLC13,651$0.33M0.0%-16.8%0.009%Search for SEC Filing on Google Icon
5/16/2023Balyasny Asset Management L.P.349,602$8.53M0.0%N/A0.223%Search for SEC Filing on Google Icon
5/16/2023Boone Capital Management LLC300,000$7.32M3.4%N/A0.191%Search for SEC Filing on Google Icon
5/15/2023Affinity Asset Advisors LLC380,000$9.27M3.1%+76.7%0.242%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Investments LP13,700$0.33M0.0%+71.3%0.009%Search for SEC Filing on Google Icon
5/15/2023Deutsche Bank AG41,333$1.01M0.0%+38.7%0.026%Search for SEC Filing on Google Icon
5/15/2023Price T Rowe Associates Inc. MD4,799,707$117.07M0.0%-0.1%3.060%Search for SEC Filing on Google Icon
5/15/2023Hood River Capital Management LLC572,876$13.97M0.5%-38.0%0.365%Search for SEC Filing on Google Icon
5/15/2023AXA S.A.201,733$4.92M0.0%-0.2%0.129%Search for SEC Filing on Google Icon
5/12/2023BlackRock Inc.4,484,941$109.39M0.0%+0.1%2.863%Search for SEC Filing on Google Icon
5/12/2023Bank of America Corp DE275,376$6.72M0.0%+22.6%0.176%Search for SEC Filing on Google Icon
5/12/2023Finepoint Capital LP539,445$13.16M5.0%+4.3%0.344%Search for SEC Filing on Google Icon
5/12/2023Sei Investments Co.12,697$0.31M0.0%-44.9%0.008%Search for SEC Filing on Google Icon
5/12/2023Dark Forest Capital Management LP3,093$75K0.0%N/A0.002%Search for SEC Filing on Google Icon
5/12/2023Charles Schwab Investment Management Inc.486,983$11.88M0.0%+0.3%0.311%Search for SEC Filing on Google Icon
5/12/2023Profund Advisors LLC39,316$0.96M0.1%N/A0.025%Search for SEC Filing on Google Icon
5/12/2023HighTower Advisors LLC74,538$1.81M0.0%-0.7%0.048%Search for SEC Filing on Google Icon
5/11/2023FMR LLC23,467,258$572.37M0.1%+0.2%14.980%Search for SEC Filing on Google Icon
5/11/2023American Century Companies Inc.254,001$6.18M0.0%+1.1%0.162%Search for SEC Filing on Google Icon
5/11/2023Rhumbline Advisers83,722$2.04M0.0%+5.0%0.053%Search for SEC Filing on Google Icon
5/11/2023E Fund Management Co. Ltd.11,932$0.29M0.0%-4.6%0.008%Search for SEC Filing on Google Icon
5/11/2023Guggenheim Capital LLC11,924$0.29M0.0%+13.6%0.008%Search for SEC Filing on Google Icon
5/10/2023Swiss National Bank135,000$3.29M0.0%-10.3%0.086%Search for SEC Filing on Google Icon
5/9/2023Principal Financial Group Inc.28,179$0.69M0.0%-5.7%0.018%Search for SEC Filing on Google Icon
5/9/2023Tower Research Capital LLC TRC 2,674$65K0.0%-28.6%0.002%Search for SEC Filing on Google Icon
5/9/2023Bank of New York Mellon Corp235,698$5.75M0.0%+0.4%0.150%Search for SEC Filing on Google Icon
5/9/2023California State Teachers Retirement System76,246$1.86M0.0%-1.1%0.049%Search for SEC Filing on Google Icon
5/8/2023Federated Hermes Inc.1,924,972$46.95M0.1%-32.9%1.229%Search for SEC Filing on Google Icon
5/4/2023Barclays PLC601,054$14.66M0.0%+31.6%0.384%Search for SEC Filing on Google Icon
5/4/2023Mirae Asset Global Investments Co. Ltd.32,772$0.80M0.0%+32.1%0.021%Search for SEC Filing on Google Icon
5/2/2023Amalgamated Bank8,096$0.20M0.0%-15.3%0.005%Search for SEC Filing on Google Icon
4/28/2023SG Americas Securities LLC29,354$0.72M0.0%+102.4%0.019%Search for SEC Filing on Google Icon
4/27/2023Arizona State Retirement System18,118$0.44M0.0%+3.1%0.012%Search for SEC Filing on Google Icon
3/23/2023ETF Managers Group LLC11,313$0.36M0.0%N/A0.007%Search for SEC Filing on Google Icon
3/23/2023MetLife Investment Management LLC30,419$0.96M0.0%+5.5%0.019%Search for SEC Filing on Google Icon
2/28/2023Voya Investment Management LLC21,479$0.68M0.0%+2.4%0.014%Search for SEC Filing on Google Icon
2/15/2023MetLife Investment Management LLC30,419$0.96M0.0%+5.5%0.019%Search for SEC Filing on Google Icon
2/15/2023Lazard Asset Management LLC10,158$0.32M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/15/2023State of Wisconsin Investment Board62,467$1.97M0.0%+4.9%0.040%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cerevel Therapeutics logo
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, develops various therapies for neuroscience diseases in the United States. It is developing Emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures in epilepsy or focal epilepsy, as well as in phase 1 trial to treat panic symptoms model. The company's products also comprise Tavapadon, a selective dopamine D1/D5 partial agonist that is in phase 3 clinical trial for the treatment of early- and late-stage Parkinson's disease; CVL-871, a selective dopamine D1/D5 partial agonist, which is in Phase 2a clinical trial to treat dementia-related apathy; and CVL-354, a selective kappa-opioid receptor antagonist to treat major depressive disorder and substance use disorder. It is also involved in the development of an M4 agonist program for the treatment of psychosis and related indications; and PDE4 inhibitor for the treatment of psychiatric, neuroinflammatory, and other disorders. Cerevel Therapeutics Holdings, Inc. was founded in 2018 and is headquartered in Cambridge, Massachusetts.
Read More on Cerevel Therapeutics

Today's Range

Now: $20.10
Low: $20.10
High: $20.65

50 Day Range

MA: $24.55
Low: $20.55
High: $30.73

52 Week Range

Now: $20.10
Low: $20.10
High: $35.98

Volume

85,076 shs

Average Volume

610,079 shs

Market Capitalization

$3.17 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.42

Who are the company insiders with the largest holdings of Cerevel Therapeutics?

Cerevel Therapeutics' top insider investors include:
  1. Perceptive Advisors Llc (Director)
  2. Marijn E Dekkers (Director)
  3. Ronald C Renaud Jr (CEO)
  4. Paul D Burgess (Insider)
  5. Mark Bodenrader (Insider)
  6. John Renger (Insider)
  7. N Anthony Coles (CEO)
  8. N Anthony Coles (Director)
  9. Abraham Ceesay (President)
  10. Deval L Patrick (Director)
Learn More about top insider investors at Cerevel Therapeutics.

Who are the major institutional investors of Cerevel Therapeutics?

Cerevel Therapeutics' top institutional shareholders include:
  1. Perceptive Advisors LLC — 6.41%
  2. BlackRock Inc. — 3.08%
  3. State Street Corp — 1.76%
  4. Artal Group S.A. — 1.04%
  5. Geode Capital Management LLC — 0.86%
  6. Polar Capital Holdings Plc — 0.58%
Learn More about top institutional investors of Cerevel Therapeutics stock.

Which major investors are selling Cerevel Therapeutics stock?

In the previous quarter, CERE stock was sold by these institutional investors:
  1. Barclays PLC
  2. Barclays PLC
  3. State Street Corp
  4. Artal Group S.A.
  5. Citigroup Inc.
  6. Simplex Trading LLC
  7. Wolverine Trading LLC
  8. Jefferies Financial Group Inc.
During the last year, company insiders that have sold Cerevel Therapeutics company stock include:
  1. Perceptive Advisors Llc (Director)
  2. Marijn E Dekkers (Director)
  3. Ronald C Renaud Jr (CEO)
  4. Paul D Burgess (Insider)
  5. Mark Bodenrader (Insider)
Learn More investors selling Cerevel Therapeutics stock.

Which major investors are buying Cerevel Therapeutics stock?

In the previous quarter, CERE stock was purchased by institutional investors including:
  1. Perceptive Advisors LLC
  2. BlackRock Inc.
  3. Woodline Partners LP
  4. Eventide Asset Management LLC
  5. Affinity Asset Advisors LLC
  6. Polar Capital Holdings Plc
  7. UniSuper Management Pty Ltd
  8. Geode Capital Management LLC
In the last year, these company insiders have bought Cerevel Therapeutics stock:
  1. Perceptive Advisors Llc (Director)
  2. Marijn E Dekkers (Director)
  3. Ronald C Renaud Jr (CEO)
Learn More investors buying Cerevel Therapeutics stock.
Free Stock Analysis Report: Buy Sell Hold Predictions on Any Stock
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Analyze Any Stock Free